Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epoetin alfa for Anemia in Subacute Rehabilitation
NCT00511901Phase 4Terminated
- Sponsor
- University of Medicine and Dentistry of New Jersey
- Start
- Nov 2005
- Primary completion
- May 2008
- Modality
- Biologic, rProtein (Recombinant Protein)
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in anemia comparing Epoetin alfa + Niferex with Placebo + Niferex (2 arms). Primary endpoint: Mean Hemoglobin Concentration at 8 weeks. Started Nov 2005; status: terminated.
02
Drugs
epoetin alfa
03
Conditions
anemia
Beyond the preview
Go deeper on NCT00511901.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00511901.